References
- Abali H, Eren OO, Dizdar O, Karada( O, Erman M, Yilmaz A, Uluç K, Erdem I, Türker A. Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma. Leuk Lymphoma 2005; 46: 1825–1828\
- Calabrese LH, Molloy ES, Huang D, Ransohoff RM. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum 2007; 56: 2116
- Coppo P, Laporte JP, Aoudjhane M, Lebon P, Isnard F, Lesage S, Gorin NC, Najman A. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 1999; 23: 401–403
- Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306: 1380–1383
- Ferrante P, Delbue S, Pagani E, Mancuso R, Marzocchetti A, Borghi E, Maserati R, Bestetti A, Cinque P. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment. J NeuroVirol 2003; 9(Suppl 1)42–46
- Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 1998; 318: 301–305
- Jensen PN, Major EO. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J NeuroVirol 2001; 7: 280–287
- Kato A, Kitamura T, Takasaka T, Tominaga T, Ishikawa A, Zheng HY, Yogo Y. Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J NeuroVirol 2004; 10: 244–249
- Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?. Ann Neurol 2006; 60: 162–173
- Koralnik IJ, Schellingerhout D, Frosch M.P. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20–1995. A 66-year-old man with a history of rheumatoid arthritis treated with adrenocorticosteroids, with the development of aphasia and right-sided weakness. N Engl J Med 1995; 332: 1773–1780
- Koralnik IJ, Schmitz JE, Lifton MA, Forman MA, Letvin NL. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J NeuroVirol 1999; 5: 430–435
- Lima MA, Marzocchetti A, Autissier P, Tompkins T, Chen Y, Gordon J, Clifford DB, Gandhi RT, Venna N, Berger JR, Koralnik IJ. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007; 81: 3361–3368
- Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 1996; 70: 7004–7012
- Monaco MC, Jensen PN, Hou J, Durham LC, Major EO. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72: 9918–9923
- Oka M, Terae S, Kobayashi R, Sawamura Y, Kudoh K, Tha KK, Yoshida M, Kaneda M, Suzuki Y, Miyasaka K. MRI in methotrexate-related leukoencephalopathy: disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy. Neuroradiology 2003; 45: 493–497
- Ransohoff RM. Natalizumab and PML. Nat Neurosci 2005; 8: 1275
- Schneider EM, Dorries K. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. Transplant Proc 1993; 25: 1271–1273